Combination of entecavir/ peginterferon alfa-2a in children with HBeAg-positive immune tolerant chronic hepatitis B virus infection

The optimal management strategy for children with immune-tolerant chronic hepatitis B virus (HBV) infection remains unknown. The purpose of this clinical trial was to determine the safety and efficacy of therapy with entecavir and peginterferon in a group of children in the immune-tolerant phase of...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Hepatology
Main Authors: Rosenthal, Philip, Ling, Simon C., Belle, Steven H., Murray, Karen F., Rodriguez-Baez, Norberto, Schwarzenberg, Sarah J., Teckman, Jeffrey, Lin, Hsing-Hua S., Schwarz, Kathleen B.
Formato: Artigo
Idioma:Inglês
Publicado: 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6465180/
https://ncbi.nlm.nih.gov/pubmed/30318613
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.30312
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares